image
image
user-login
arrow
IBUCIN SAMIR REMEDIES LTD.
I

IBUCIN
SAMIR REMEDIES LTD.

IBUCIN is a Trademark filed on Aug 27, 1996 in through IP Office.The Trademark is registered to SAMIR REMEDIES LTD. and was filed by attorney.

I

IBUCIN SAMIR REMEDIES LTD. Trademark Information

Application ID

720837

Status

Abandoned

Date of Application

Aug 27, 1996

Classes

5

Proprietor(s)

SAMIR REMEDIES LTD.

Related trademark

IBUCIN VIVIDMARGI INVESTMENTS PRIVATE LIMITED.

Opposed

Class -5
IBUCIN M/S.VENKAT PHARMA LTD.,

Refused

Class -5
IBUCIN R.S.BHARECH

Withdrawn

Class -5
IBUCIN SH. ASHOK MONGA

Exam Report Issued

Class -5

FAQs

The application for IBUCIN was made on Aug 27, 1996
The trademark applicant for IBUCIN is SAMIR REMEDIES LTD..
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Abandoned.
Listed application Id of IBUCIN is 720837.
IBUCIN Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.